Brionna Mendoza

An illustrated picture shows two cartoon doctors, one holding up a magnifying glass to a cartoon brain.
Conference Coverage
Flexible Dosing of Esketamine Nasal Spray Effective Over Long-Term
11/12/2024
Analysis of a long-term extension study of flexibly dosed esketamine nasal spray, in combination with an oral antidepressant, found durable long-term efficacy and safety of the treatment whether dosed weekly, every other week, or every 4...
Analysis of a long-term extension study of flexibly dosed esketamine nasal spray, in combination with an oral antidepressant, found durable long-term efficacy and safety of the treatment whether dosed weekly, every other week, or every 4...
Analysis of a long-term...
11/12/2024
Psychiatry & Behavioral Health
A illustrated cartoon of someone sitting under a raincloud
Conference Coverage
Anhedonia Highlighted as a Frequently Misunderstood Symptom in Psychiatric Conditions at 2024 NEI Fall Congress
11/11/2024
Anhedonia is a common feature of depression and other psychiatric conditions. Distinct from emotional blunting or apathy, patients experiencing anhedonia, “have a reduced ability to experience pleasure or interest in things previously...
Anhedonia is a common feature of depression and other psychiatric conditions. Distinct from emotional blunting or apathy, patients experiencing anhedonia, “have a reduced ability to experience pleasure or interest in things previously...
Anhedonia is a common feature of...
11/11/2024
Psychiatry & Behavioral Health
Stephen M. Stahl
Conference Coverage
At the NEI Fall Congress, Leading Faculty Reflect on the Evolution of Psychiatry and What the Future May Hold
11/08/2024
The 2024 Neuroscience Education Institute (NEI) Fall Congress commenced with opening remarks from Andrew J. Cutler, MD, Chairman, and the highly anticipated keynote address from Stephen M. Stahl, MD, PhD, DSc (Hon.), Chairman Emeritus.
The 2024 Neuroscience Education Institute (NEI) Fall Congress commenced with opening remarks from Andrew J. Cutler, MD, Chairman, and the highly anticipated keynote address from Stephen M. Stahl, MD, PhD, DSc (Hon.), Chairman Emeritus.
The 2024 Neuroscience Education...
11/08/2024
Psychiatry & Behavioral Health
Conference presenter
News
Olanzapine/Samidorphan Demonstrates Favorable Safety Profile in 4-Year Open-Label Study
11/01/2024
Combination olanzapine/samidorphan (OLZ/SAM) maintained consistent symptom control in patients with schizophrenia or bipolar I disorder and demonstrated a favorable long-term safety profile over 4 years consistent with previous studies.
Combination olanzapine/samidorphan (OLZ/SAM) maintained consistent symptom control in patients with schizophrenia or bipolar I disorder and demonstrated a favorable long-term safety profile over 4 years consistent with previous studies.
Combination...
11/01/2024
Psych Congress Network
News
Delirium Episodes in Elderly Patients Linked to Substantial Dementia Risk Within 5 Years
06/08/2022
Episodes of delirium are closely linked to future development of dementia, according to a new study published in the Journal of Neurology, Neurosurgery, & Psychiatry.
Episodes of delirium are closely linked to future development of dementia, according to a new study published in the Journal of Neurology, Neurosurgery, & Psychiatry.
Episodes of delirium are closely...
06/08/2022
Neurology
News
New ALS Drug Gets OK From FDA, Despite Lingering Efficacy Concerns
09/30/2022
On Thursday, the US Food and Drug Administration (FDA) approved sodium phenylbutyrate/taurursodiol (Relyvrio) to treat patients living with amyotrophic lateral sclerosis (ALS), also commonly known as Lou Gehrig’s disease.
On Thursday, the US Food and Drug Administration (FDA) approved sodium phenylbutyrate/taurursodiol (Relyvrio) to treat patients living with amyotrophic lateral sclerosis (ALS), also commonly known as Lou Gehrig’s disease.
On Thursday, the US Food and...
09/30/2022
Neurology
Christine Moutier, MD, Chief Medical Officer for the American Foundation for Suicide Prevention (AFSP).
News
Transformative ‘Talk Therapy:’ Psych Congress Keynote Considers Medicinal Music
09/07/2023
The 36th Annual Psych Congress meeting convened on Wednesday, September 6th, in Nashville, Tennessee, with a robust pre-conference program that concluded with the second-ever Eric C. Arauz Memorial Keynote Address.
The 36th Annual Psych Congress meeting convened on Wednesday, September 6th, in Nashville, Tennessee, with a robust pre-conference program that concluded with the second-ever Eric C. Arauz Memorial Keynote Address.
The 36th Annual Psych Congress...
09/07/2023
Psych Congress Network
News
Reboxetine Prescribed Alone Reduces Sleep Apnea Severity
10/25/2022
Reboxetine prescribed alone can reduce the severity of obstructive sleep apnea (OSA), according to new findings published in the Journal of Clinical Sleep Medicine.
Reboxetine prescribed alone can reduce the severity of obstructive sleep apnea (OSA), according to new findings published in the Journal of Clinical Sleep Medicine.
Reboxetine prescribed alone can...
10/25/2022
Neurology
News
Anxiety Blood Test Examining Biomarkers May Help Optimize Individual Treatment
03/28/2023
A blood test for anxiety examining specific biomarkers to determine individual anxiety development risk, severity, and optimized therapy options has been developed.
A blood test for anxiety examining specific biomarkers to determine individual anxiety development risk, severity, and optimized therapy options has been developed.
A blood test for anxiety...
03/28/2023
Psych Congress Network
two animated heads in profile
News
Blonanserin May Improve Social Functioning for Individuals With First-Episode Schizophrenia
04/05/2024
Blonanserin, a novel atypical antipsychotic marketed under the brand name Lonasen, has demonstrated efficacy for improving social functioning in individuals with first-episode schizophrenia.
Blonanserin, a novel atypical antipsychotic marketed under the brand name Lonasen, has demonstrated efficacy for improving social functioning in individuals with first-episode schizophrenia.
Blonanserin, a novel atypical...
04/05/2024
Psych Congress Network

Upcoming Events

February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
SAWC Spring
April 30 ⁠–⁠ May 4
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 5
WoundCon
May 1 ⁠–⁠ May 3
Senior Living Executive Conference
May 19 ⁠–⁠ May 21
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use